Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn’s Disease

Overview of attention for article published in Antibiotics, July 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 3 news outlets

twitter: 8 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 3 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 17,669 followers.

RT @propelacure: A triple antimicrobial therapy targeting a specific pathogen is a controversial #Crohns treatment, but it produced favorab…

01 Oct 2024

Reply Repost Favourite

RT @propelacure: A triple antimicrobial therapy targeting a specific pathogen is a controversial #Crohns treatment, but it produced favorab…

01 Oct 2024

Reply Repost Favourite

RT @propelacure: A triple antimicrobial therapy targeting a specific pathogen is a controversial #Crohns treatment, but it produced favorab…

01 Oct 2024

Reply Repost Favourite

A triple antimicrobial therapy targeting a specific pathogen is a controversial #Crohns treatment, but it produced favorable results in a subset of patients in this recently published study even though its mechanism may not be fully understood. https://t.

30 Sep 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.